Thrombosis may occur in any vein, but in clinical practice the problem of venous thrombosis is most often encountered in the lower limbs. In the United States, in particular, it is usual to distinguish two types of venous thrombosis, phlebothrombosis, in which the thrombosis is a simple noninflammatory process, and thrombophlebitis, in which the thrombosis is due to or accompanied by a local inflammatory reaction in the wall of the vein. It is doubtful whether this classification is helpful either diagnostically or therapeutically. A more useful subdivision is into cases in which thrombosis is confined to superficial veins and those in which deep veins are involved.
Aetiological Factors
Thrombosis probably never occurs in a normal vein with normal blood-flow, though occasionally one encounters a patient with an apparently spontaneous venous thrombosis in whom no obvious aetiological factor can be found. Some of these cases occur after strenuous muscular activity, and they are particularly common in tall men.' Most cases of venous thrombosis occur in circumstances in which it is obvious that there is an abnormality of the vein, a slowing of the blood-flow, or some qualitative alteration of the blood, or any combination of these factors. The commonest and most obvious example of this is varicose veins, in which the vein is clearly abnormal and the blood-flow sluggish. Any external pressure upon a vein with its relatively thin wall and low intravascular pressure will impede the blood-flow and cause thrombosis distal to the obstruction ; pelvic tumours and the gravid uterus are common examples of this. The greater incidence of deep venous thrombosis in the left lower limb is thought to be due to the fact that the anatomical relations of the left common iliac vein make it more subject to compression than the right.
Bed rest is a well-known cause of venous thrombosis in the lower limbs. The loss of the normal pumping activity of the muscles of the legs, leading to slowing of the venous flow, is only one of the factors concerned. The veins in the calf muscles, particularly in soleus, are easily traumatized and form a dependent pool of stagnant blood when a patient is supine, so that thrombosis readily occurs and spreads to involve the posterior tibial and popliteal veins. The other common site for thrombosis to start in a bed-ridden patient is in the common femoral vein just distal to the inguinal ligament, as this is the lowest point in the venous system of the lower limbs in a supine or semi-recumbent patient. 
Anticoagulant Therapy
It would be out of place in an article of this nature to discuss anticoagulant therapy in detail, but a few practical points in relation to its use in venous thrombosis can be given. For prophylactic use heparin is unnecessary: one of the oral anticoagulant drugs, preferably warfarin, should be used. An initial dose of 30 to 50 mg. of warfarin should be given whenever the decision to start treatment is made, and subsequent dosage determined by the results of whichever laboratory test is used for control. In established deep-vein thrombosis heparin should be given in an initial intravenous dose of 15,000 units, followed by 10,000 units. at intervals of four to six hours. Whether to continue with heparin alone or to change to an oral anticoagulant is largely a matter of personal preference. Many surgeons believe that heparin is the better anticoagulant in these patients and continue with it for 10 to 14 days, which is often as long as is thought necessary. There is good evidence that treatment with heparin is followed by rapid improvement in the local clinical signs,"8 but the risks of bleeding with prolonged heparin treatment are undoubtedly greater than with oral anticoagulants.
If the policy is to use heparin only for its immediate effect, and to maintain therapy with an oral drug, then the loading dose of the latter should be given at the same time as the initial dose of heparin. In these circumstances heparin can be stopped when the results of laboratory tests show that the depression of the coagulation factors has reached the so-called " therapeutic level." As far as laboratory tests are concerned there is little to choose between them, and the decision whether to use the " Thrombotest " or Quick's one-stage " prothrombin time " is a matter of personal preference. If the former is used the therapeutic level to be aimed at is 5 to 10% ; if the latter, two to three times the normal. l 7
Special Types of Venous Thrombosis Thrombophlebitis Migrans
In this condition there are recurrent episodes of thrombosis affecting short lengths of superficial veins, usually in the extremities, but also sometimes on the trunk. Deep-vein thrombosis is uncommon and pulmonary embolism is rare. In some of these cases arterial lesions are also present, and then the diagnosis is thromboangiitis obliterans ; others are associated with carcinoma, but many of the patients continue to have A.-In recent years there has been much interest in the passage of drugs and other substances across the placental barrier, and there are a number of excellent reviews dealing with this subject.1' In general terms it can be said that almost any substance can penetrate the placental barrier to some extent, although some drugs are so rapidly destroyed that they do not reach an effective concentration in the maternal blood. When the degree of permeability is low the amount which reaches the foetus is neither pharmacologically active nor physiologically detectable.
It is possible to recognize the passage of drugs through the placenta either by detecting their presence in the foetal blood after administration to the mother or by observing their known pharmacological effects on the foetus. For example, it can be inferred that antithyroid drugs cross the placental barrier because babies born to mothers receiving these drugs have enlarged thyroids. Similarly, oral anticoagulant drugs administered during pregnancy can cause a haemorrhagic state in the foetus. Naturally, nfost information is available about drugs which are used in obstetrics.
All the commonly used hypnotics, analgesics, narcotics, and anaesthetics cross the placental barrier readily and rapidly. The notable exceptions are the muscle relaxant drugs such as tubocurarine, gallamine, decamethonium, and suxamethonium, which, when administered in the usual doses, apparently do not cross the placenta. In animals, however, it is found that when these drugs are given in large doses they do affect the foetus, so that the placenta is a relative rather than an absolute barrier to their passage. Of other
